FDA Commissioner Scott Gottlieb has taken to Twitter to say that due to the partial shutdown, the FDA cannot accept new 2019 user fees.
With major leadership changes, grant disruptions and terminations, and a stoked distrust in science, Steven Artandi, the director of Stanford Cancer Center, worries that young investigators will feel disenchanted by the U.S. research atmosphere and take their work and study elsewhere.
